014-22 – Early impairment of hippocampal synaptic plasticity in the TgF344-AD rat model for Alzheimer’s disease

014-22
Early impairment of hippocampal synaptic plasticity in the TgF344-AD rat model for Alzheimer’s disease
Yuhong Sun
Division of Pharmacy and Optometry, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
The Abstract
Abstract Body

Introduction:
Hippocampal hyper-excitability is a causative factor in memory impairment and has been documented in many animal models for Alzheimer’s disease (AD). Here, we sought to track AD-related prodromal changes in hippocampal synaptic strength and plasticity in the TgF344-AD rat model, which exhibits age-dependent beta-amyloid (Aß) aggregation, tauopathy and neuroinflammation.

Methods:
Electrophysiology: Evoked responses in dorsal CA1 were recorded following CA3 Schaffer stimulation in urethane-anaesthetised 6- and 9-month-old male TgF344-AD (TG) and wild-type (WT) rats, to determine the induction properties for short- and long-term synaptic plasticity and baseline connectivity.
Post-mortem: Parvalbumin (PV) levels were measured in dorsal hippocampus by Simple Western analysis and immunohistochemistry of age-matched rats.

Results:
In contrast to 6-month-old TG rats, the 9-month-old TGs showed significantly smaller paired-pulse facilitation, and this cohort of TG animals also displayed an upwardly-shifted baseline input/output curve. Long-term potentiation induced by high-frequency stimulation was significantly reduced in CA1 of 6- and 9-month-old TG rats. LTP depotentiation tested in 6-month-old rats was much stronger in TG compared to WT. Immunohistochemical analysis revealed significantly lower PV levels in CA2/3 region, but not CA1 or dentate gyrus of the hippocampus in 9-month-old TG rats. Work is underway to determine PV changes at 6 months old.

Conclusions:
These results suggest that reduced inhibition upstream of the CA3-CA1 synapse leads to abnormal changes in synaptic plasticity, which might imply a possible mechanism for disease progression at pre-symptomatic stage of AD.

Additional Authors
Lauren Rimmer
Marie-Astrid Pezze
Tobias Bast
John Gigg
Michael Harte
Additional Institutions
Division of Neuroscience and Experimental Psychology, Faculty of Biology, Medicine and Health, University of Manchester, Manchester, UK
School of Psychology, Neuroscience@Nottingham, University of Nottingham, Nottingham, UK